✦ LIBER ✦

Impact of weekend admissions on quality of care and outcomes in patients with acute myeloid leukemia

✍ Scribed by Nelli Bejanyan; Alex Z. Fu; Aleksandr Lazaryan; Rao Fu; Matt Kalaycio; Anjali Advani; Ronald Sobecks; Edward Copelan; Jaroslaw P. Maciejewski; Mikkael A. Sekeres

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 238 KB
Volume: 116
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25086

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcomes and quality of care in acute my

Outcomes and quality of care in acute myeloid leukemia over 40 years

✍ Shabbir M. H. Alibhai; Marc Leach; Mark D. Minden; Joseph Brandwein 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB 👁 1 views

Outcomes and charges of elderly patients

Outcomes and charges of elderly patients with acute myeloid leukemia

✍ Laura M. Katz; Jamie B. Howell; John J. Doyle; Lee S. Stern; Lisa C. Rosenblatt; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 2 views

A retrospective database analysis was conducted to evaluate hospitalization outcomes and charges among elderly acute myeloid leukemia (AML) patients. The data source was a longitudinal (2000)(2001)(2002)(2003) inpatient database from 28 US hospitals. Data on 275 AML patients aged 60 and older were a

Impact of remission induction chemothera

Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia

✍ Rachid Baz; Cristina Rodriguez; Alex Z. Fu; Rony Abou Jawde; Matt Kalaycio; Anja 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## BACKGROUND. Significant controversy surrounds the use of remission induction chemotherapy (IC) in older adults with acute myeloid leukemia (AML). Earlier clinical trials have yielded conflicting results and possibly a minor survival benefit, often offset by a longer hospitalization

Survival and predictors of outcome in pa

Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit

✍ Snehal G. Thakkar; Alex Z. Fu; John W. Sweetenham; Zachariah A. Mciver; Sanjay R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views

## Abstract ## BACKGROUND. Predictors of outcome and rates of successful discharge have not been defined for patients with acute leukemia admitted to intensive care units (ICUs) in the US. ## METHODS. This is a retrospective analysis of 90 patients with acute leukemia (no history of bone marrow

Transfusion independence in patients wit

Transfusion independence in patients with myelodysplastic syndromes : Impact on outcomes and quality of life

✍ Lodovico Balducci 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 1 views

In vivo expression of survivin and its s

In vivo expression of survivin and its splice variant survivin-2B: Impact on clinical outcome in acute myeloid leukemia

✍ Mandy Wagner; Karin Schmelz; Christian Wuchter; Wolf-Dieter Ludwig; Bernd Dörken 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 229 KB 👁 1 views

## Abstract Survivin, a member of the inhibitor of apoptosis protein family, is expressed in most human cancers, but undetectable in normal differentiated adult tissue __in vivo__. Because of this cancer‐related expression, survivin is a promising target for cancer therapy. To determine the express